Alkermes
ALKS
#2383
Rank
$7.71 B
Marketcap
$45.90
Share price
3.05%
Change (1 day)
40.58%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2023 (TTM): $1.30

According to Alkermes's latest financial reports the company's current EPS (TTM) is $0.40. In 2022 the company made an earnings per share (EPS) of -$0.96 a decrease over its 2021 EPS that were of -$0.30.

EPS history for Alkermes from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.30-235.42%
2022-$0.96220%
2021-$0.30-57.19%
2020-$0.70-44.38%
2019-$1.2641.57%
2018-$0.89-13.59%
2017-$1.03-24.82%
2016-$1.37-9.87%
2015-$1.52660%
2014-$0.20-242.86%
2013$0.14-137.84%
2012-$0.37-39.34%
2011-$0.6124.49%
2010-$0.4919.51%
2009-$0.41-130.37%
2008$1.35-27.81%
2007$1.871600%
2006$0.11-164.71%
2005-$0.17-81.91%
2004-$0.94-40.88%
2003-$1.598.9%
2002-$1.4675.9%
2001-$0.833.75%
2000-$0.80-37.98%
1999-$1.2977.93%
1998-$0.73123.08%
1997-$0.32-43.97%
1996-$0.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 1,571.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25 1,212.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.76 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.90 375.73%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$4.52 1,030.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$6.68 1,570.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-$50.31-12,677.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$0.63 57.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel